检索结果 - Ruby Ray
- Showing 1 - 4 results of 4
-
1
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer 由 Chris Hurt, Stephen Falk, Tom Crosby, A. McDonald, Ruby Ray, George Joseph, J. Staffurth, Ross A. Abrams, Gareth Griffiths, Tim Maughan, Somnath Mukherjee
出版 2017Artigo -
2
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer 由 Tom Crosby, Chris Hurt, Stephen Falk, Simon Gollins, John Staffurth, Ruby Ray, John Bridgewater, J I Geh, David Cunningham, Jane Blazeby, Rajarshi Roy, Tim Maughan, Gareth Griffiths, Saptarshi Mukherjee
出版 2017Artigo -
3
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial 由 T. Crosby, Chris Hurt, Stephen Falk, Simon Gollins, Somnath Mukherjee, John Staffurth, Ruby Ray, Nadim Bashir, John Bridgewater, J I Geh, David Cunningham, Jane Blazeby, Rajarshi Roy, Tim Maughan, Gareth Griffiths
出版 2013Artigo -
4
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial 由 Somnath Mukherjee, Chris Hurt, John Bridgewater, Stephen Falk, Sebastian Cummins, Harpreet Wasan, Tom Crosby, Catherine Jephcott, Rajarshi Roy, Ganesh Radhakrishna, Alec McDonald, Ruby Ray, George Joseph, John Staffurth, Ross A. Abrams, Gareth Griffiths, Tim Maughan
出版 2013Artigo
相关主题
Cancer
Capecitabine
Colorectal cancer
Internal medicine
Medicine
Surgery
Chemoradiotherapy
Oncology
Phases of clinical research
Radiation therapy
Cetuximab
Chemotherapy
Clinical endpoint
Clinical trial
Confidence interval
Gastroenterology
Gemcitabine
Hazard ratio
Pancreatic cancer
Adenocarcinoma
Deoxycytidine
Fluorouracil
Induction chemotherapy
Randomized controlled trial
Regimen